Session » Infection-related Rheumatic Disease Poster
-
Abstract Number: 0621
Effectiveness of Screening in Patients with Rheumatic Disease Before Commencing Biologic Therapy and Risk of Active Tuberculosis
-
Abstract Number: 0622
Infection-induced MPO-ANCA Associated Vasculitis: A Systematic Review of Published Case Reports
-
Abstract Number: 0623
Cytokine Storm: Outcomes in SARS-CoV-2 Patients Treated with Biologics in a Rheumatology Cohort
-
Abstract Number: 0624
Association of Regional Body Composition and Physical Function Using the Short Physical Performance Battery Among Peruvian Women with HIV
-
Abstract Number: 0625
Machine Learning Model to Predict Culture Positivity in Suspected Septic Arthritis
-
Abstract Number: 0626
Early Rise in CRP Is Associated with Progression to Respiratory Failure and Intubation in COVID-19 Patients
-
Abstract Number: 0627
Complications of COVID-19 Infection in Patients with Rheumatic Disease: A Case Series
-
Abstract Number: 0628
Factors Associated with Knee Osteoarthritis in an Outpatient HIV-1 Clinic over a 26 Year Interval
-
Abstract Number: 0629
COVID-19 Among Patients with Immune-mediated Inflammatory Diseases: A Descriptive Study
-
Abstract Number: 0631
Clinical Manifestations and Outcomes in DMARD-Naïve Patients with Chronic Chikungunya Arthritis
-
Abstract Number: 0632
Systems Approach to Understanding Reasons for Influenza Vaccine Hesitancy in Rheumatic Diseases
-
Abstract Number: 0633
Vitamin D Serum Status in a Cohort of COVID-19 Patients
-
Abstract Number: 0634
Influenza Knowledge and Barriers to Vaccination in Immunosuppressed Patients in the Pediatric Rheumatology Clinic
-
Abstract Number: 0635
Hydroxychloroquine Is Not Associated with Reduced Influenza Admissions in Rheumatoid Arthritis Patients
-
Abstract Number: 0636
Rheumatology Patient Experience and Trends During the SARS-COV-2 Pandemic
-
Abstract Number: 0637
Clinical and Treatment Features of Rheumatoid Arthritis in HIV-Infected Individuals Followed Longitudinally over Time
-
Abstract Number: 0638
Serological Evidence of SARS-CoV-2 in Symptomatic Patients Under Biological Treatment in a Rheumatology Service
-
Abstract Number: 0639
Immunological Abnormalities in a SARS-CoV-2-Cytokine Release Syndrome Rheumatology Cohort
-
Abstract Number: 0640
Covid-19 and Rheumatic and Musculoskeletal Disease Patients: Infection Rates, Attitudes and Medication Adherence
-
Abstract Number: 0641
Cohort of Rheumatic Patients Treated with Rituximab and COVID-19: Does Rituximab Treatment Increases the Severity of SARS-COV2 Infection?
-
Abstract Number: 0642
COVID-19 Infection in Rheumatologic Patients on Treatment with Targeted Therapies
-
Abstract Number: 0643
Use of Biologic Treatment and Risk to Be Admitted for COVID-19 Infection
-
Abstract Number: 0644
Characterizations of Cytokine Storm Associated with COVID19